Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 916-533-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
IN VITRO BACTERIAL GENE MUTATION
In the key study (Hargitai, 2012) the mutagenic potential of the test material was assessed in an Ames test conducted under GLP conditions and in line with the standardised guidelines OECD 471, EU Method B.13/14 and EPA OPPTS 870.5100. S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2uvrA were exposed to the test material at concentrations of 5000, 1581, 500, 158.1, 50, 15.81, 5 and 1.581 µg/plate using the plate incorporation method. Positive and solvent controls were run concurrently for comparison.
Under the conditions of the test, the test material did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used, therefore the test material is considered to be non-mutagenic. Cytotoxicity was observed in both S. typhimurium and E. coli at certain concentrations at or above 500 µg/plate, however this was dependant on the strain and the presence or absence of metabolic activation.
IN VITRO MAMMALIAN CELL CYTOGENICITY
In the key study (Murata, 2011) the clastogneic potential of the test material was determined in an in vitro mammalian chromosome aberration test with Chinese hamster lung fibroblasts (V79). The study was performed under GLP conditions and according to OECD 473. Two experiments were performed during this study. Experiment 1 was conducted with a short term exposure of 6 hours in the presence and absence of metabolic activation system S9. Experiment 2 was conducted with continuous exposure for either 24 or 48 hours in the absence of metabolic activation. Solvent and positive controls were run concurrently for comparison.
Under the conditions of the test, the frequency of structural and numerical chromosome aberrations was less than 5.0%, determined in test systems exposed under short term (with and without metabolic activation) and continuous exposure (without metabolic activation). Cytotoxicity was observed at concentrations ≥ 1.89 mg/mL under short term exposure, independent of metabolic activation. Under continuous exposure cytotoxicity was also observed at concentrations ≥ 0.945 mg/mL without metabolic activation. Accordingly the test material was considered to be negative for clastogenic potential.
IN VITRO MAMMALIAN CELL GENE MUTATION
In the key study (Hargitai, 2013) the mutagenic potential of the test material was determined in anin vitromouse lymphoma assay, conducted under GLP conditions and in line with the standardised guidelines OECD 476 and EU Method B.17.
Cultures of mouse lymphoma L5178Y cells were exposed to the test material at concentrations ranging from 6.25 to 1000 μg/mL, in two assays, both with and without the addition of a rat metabolic activation system (S9 fraction). Assay 1 was performed with two experiments, both with a three hour exposure period; however the first was performed in the presence and the second in the absence of metabolic activation. Assay 2 was performed again with two experiments. The first was performed with metabolic activation and an exposure period of 3 hours, whereas the second experiment was performed without metabolic activation with a 24 hour exposure period. All experiments were conducted with an expression time of 3 days and a selection time of 2 weeks, with trifuorothymidine as the selection agent. Treatment with the test material did not result in a statistically significant increase in mutation frequencies either in the presence or absence of metabolic activation system in the Mouse Lymphoma Assay. The test material was therefore considered to have no mutagenic potential under the conditions of this test.
Justification for selection of genetic toxicity endpoint
One single study could not be selected as key, since all three studies are necessary to address this endpoint. The three studies assess different types of in vitro genetic toxicity: bacterial gene mutation, mammalian chromosome aberration and mammalian gene mutation. All three studies were performed under GLP conditions and in accordance with standardised guidelines. The studies have been assigned a reliability score of 1 in line with Klimisch (1997).
Short description of key information:
Ames test: Negative, OECD 471, EU Method B.13/14 and EPA OPPTS 870.5100, Hargitai (2012).
Chromosome aberration assay: Negative, OECD 473, Murata (2011).
Mouse lymphoma assay: Negative, OECD 476 and EU Method B.17, Hargitai (2013).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the submitted in vitro data, testing does not indicate any evidence of genetic toxicity as a result of exposure to the test material. In accordance with criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, the test material does not require classification under genetic toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.